AVXL
Anavex Life Sciences Corp
NASDAQ: AVXL · HEALTHCARE · BIOTECHNOLOGY
$3.34
+2.45% today
Updated 2026-04-30
Market cap
$309.52M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.46
Dividend yield
—
52W range
$3 – $14
Volume
1.4M
Anavex Life Sciences Corp (AVXL) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+18.8%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+57.1%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+11.0%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
+25.3%
2025-11-25
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-09 | $-0.06 | +50.0% | $4.10 | $3.96 | -3.4% |
| 2025-11-25 | $-0.11 | +22.9% | $3.08 | $3.86 | +25.3% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.12 | $-0.06 | +50.0% | — | — |
| 2025-09-30 | $-0.14 | $-0.11 | +22.9% | — | — |
| 2025-06-30 | $-0.15 | $-0.16 | -9.8% | — | — |
| 2025-03-31 | $-0.15 | $-0.13 | +12.3% | — | — |
| 2024-12-31 | $-0.17 | $-0.14 | +17.6% | — | — |
| 2024-09-30 | $-0.17 | $-0.14 | +17.6% | — | — |
| 2024-06-30 | $-0.16 | $-0.14 | +12.5% | — | — |
| 2024-03-31 | $-0.11 | $-0.13 | -18.2% | — | — |
| 2023-12-31 | $-0.14 | $-0.11 | +21.4% | — | — |
| 2023-09-30 | $-0.15 | $-0.12 | +20.0% | — | — |
| 2023-06-30 | $-0.17 | $-0.14 | +17.6% | — | — |
Frequently asked questions
Has Anavex Life Sciences Corp beaten earnings estimates?
Anavex Life Sciences Corp has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +18.8% over the last 4 quarters.
How does AVXL stock react to earnings?
AVXL stock has moved an average of +11.0% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.